399 related articles for article (PubMed ID: 15308121)
1. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
2. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
Minamiguchi H; Wingard JR; Laver JH; Mainali ES; Shultz LD; Ogawa M
Biol Blood Marrow Transplant; 2005 Jul; 11(7):487-94. PubMed ID: 15983548
[TBL] [Abstract][Full Text] [Related]
3. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
5. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
6. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
7. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
[TBL] [Abstract][Full Text] [Related]
8. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
9. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.
Shultz LD; Banuelos S; Lyons B; Samuels R; Burzenski L; Gott B; Lang P; Leif J; Appel M; Rossini A; Greiner DL
Transplantation; 2003 Oct; 76(7):1036-42. PubMed ID: 14557749
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
11. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
12. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
Sutton VR; Estella E; Li C; Chen M; Thomas HE; Kay TW; Trapani JA
Transplantation; 2006 Jan; 81(2):146-54. PubMed ID: 16436955
[TBL] [Abstract][Full Text] [Related]
13. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice.
Wegmann DR; Shehadeh N; Lafferty KJ; Norbury-Glaser M; Gill RG; Daniel D
J Autoimmun; 1993 Oct; 6(5):517-27. PubMed ID: 7902094
[TBL] [Abstract][Full Text] [Related]
14. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
Saldeen J; Sandler S; Bendtzen K; Welsh N
Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
[TBL] [Abstract][Full Text] [Related]
15. Importance of hyperglycemia on the primary function of allogeneic islet transplants.
Makhlouf L; Duvivier-Kali VF; Bonner-Weir S; Dieperink H; Weir GC; Sayegh MH
Transplantation; 2003 Aug; 76(4):657-64. PubMed ID: 12973104
[TBL] [Abstract][Full Text] [Related]
16. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.
Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Styche AJ; Trucco M
Cell Transplant; 2002; 11(2):113-23. PubMed ID: 12099635
[TBL] [Abstract][Full Text] [Related]
17. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
Reddy S; Liu W; Elliott RB
Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
[TBL] [Abstract][Full Text] [Related]
18. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
19. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
20. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
